Suren Dutia

Suren G.
Dutia is Director at Flint Rehabilitation Devices LLC since 2016, Director at Vahan Technologies India Pvt Ltd. since 2016, Lead Independent Director at Citius Oncology, Inc. since 2024, and Independent Director at Citius Pharmaceuticals, Inc. since 2015.
Former roles include Chairman, President & Chief Executive Officer at Xscribe Corp from 1989 to 1998; President & Chief Executive Officer at Photomatrix Corp.
from 1989 to 1999; Chief Executive Officer at The Indus Entrepreneurs from 2006 to 2010; Chairman at AccelPath LLC; Independent Director at Technest Holdings, Inc. from 2011 to 2012; Director at Anvita, Inc. from 2000 to 2011; Director at TreeFrog Developments, Inc. from 2011 to 2013; Director at Otter Products LLC from 2011 to 2013; Independent Director at AccelPath, Inc. from 2012 to 2013; Director at Nanopore Diagnostics LLC; and.
President at Acterna Corp.
Education includes undergraduate and graduate degrees from Washington University in St. Louis and an MBA from the University of Dallas.